Micro Interventional Devices, Inc., a Bethlehem, PA-based cardiovascular medical device company, has received a $100k loan from the Ben Franklin Technology Partners of Northeastern Pennsylvania (BFTP/NEP)
The company intends to use the funding to develop a new, minimally invasive structural heart repair product called Permaseal™, and begin commercializing it.
Founded in 2010 and led by CEO Michael P.Whitman and CSO Willard Hennemann, PhD, Micro Interventional Devices is developing solutions for structural
heart repair procedures, including transcatheter aortic valve implantation (TAVI), transcatheter mitral valve replacement, LVAD placement, mitral valve repair,
valvuloplasty, aortic arch repair, ASD and VSD closure, left atrial appendage closure, ablation of arrhythmia and other emerging structural heart repair